Safety and efficacy of droxidopa (Norther™) for the treatment of symptomatic neurogenic orthostatic by (NOH) in patients with Parkinson's disease (PD)

被引：0

|

作者：

Mathias, C. J.

Kaufmann, H.

机构：

来源：

MOVEMENT DISORDERS | 2010年 / 25卷 / 07期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：S405 / S406

页数：2

相关论文

共 50 条

[41] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
Kremens, Daniel
Lew, Mark
Claassen, Daniel
Goodman, Brent P.
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S29 - S31
[42] Adding droxidopa to fludrocortisone or midodrine in a patient with neurogenic orthostatic hypotension and Parkinson disease
Daniel Kremens
Mark Lew
Daniel Claassen
Brent P. Goodman
Clinical Autonomic Research, 2017, 27 : 29 - 31
[43] Long-term evaluation of 24 hour ambulatory blood pressure monitoring in patients with Parkinson's disease and symptomatic neurogenic orthostatic hypotension treated with droxidopa
Brillman, S.
Husain, S.
Isaacson, S. H.
MOVEMENT DISORDERS, 2015, 30 : S72 - S73
[44] Titrating droxidopa to maximize symptomatic benefit in a patient with Parkinson disease and neurogenic orthostatic hypotension (vol 27, pg S15, 2017)
Gupta, Fiona
Karabin, Beverly
Mehdirad, Ali
CLINICAL AUTONOMIC RESEARCH, 2017, 27 (06) : 431 - 431
[45] Number-needed-to-treat analysis of droxidopa in patients with symptomatic neurogenic orthostatic hypotension
Francois, C.
Rowse, G. J.
Hauser, R. A.
Hewitt, L. A.
MOVEMENT DISORDERS, 2015, 30 : S86 - S86
[46] Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension
Mehdirad, Ali
Karabin, Beverly
Gupta, Fiona
CLINICAL AUTONOMIC RESEARCH, 2017, 27 : S25 - S27
[47] Managing neurogenic orthostatic hypotension with droxidopa in a patient with Parkinson disease, atrial fibrillation, and hypertension
Ali Mehdirad
Beverly Karabin
Fiona Gupta
Clinical Autonomic Research, 2017, 27 : 25 - 27
[48] Durability of effect with long-term droxidopa treatment in patients with symptomatic NOH
Isaacson, S.
Liang, G.
Lisk, J. P.
MOVEMENT DISORDERS, 2015, 30 : S93 - S93
[49] Real-world droxidopa or midodrine treatment persistence in patients with neurogenic orthostatic hypotension or orthostatic hypotension
Kymes, Steven M.
Sullivan, Christine
Jackson, Kenneth
Raj, Satish R.
AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL, 2020, 225
[50] Subgroup efficacy analysis: Orthostatic hypotension questionnaire composite score in patients with neurogenic orthostatic hypotension treated with droxidopa
Wenning, G.
Low, P.
Szakacs, C.
Kaufmann, H.
MOVEMENT DISORDERS, 2012, 27 : S429 - S429

← 1 2 3 4 5 →